188 related articles for article (PubMed ID: 35592624)
1. Primary hyperoxaluria: the pediatric nephrologist's point of view.
Ben-Shalom E; Garrelfs SF; Groothoff JW
Clin Kidney J; 2022 May; 15(Suppl 1):i23-i28. PubMed ID: 35592624
[TBL] [Abstract][Full Text] [Related]
2. Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children.
Ellis SR; Hulton SA; McKiernan PJ; de Ville de Goyet J; Kelly DA
Nephrol Dial Transplant; 2001 Feb; 16(2):348-54. PubMed ID: 11158411
[TBL] [Abstract][Full Text] [Related]
3. Primary hyperoxaluria: the adult nephrologist's point of view.
Moochhala SH; Worcester EM
Clin Kidney J; 2022 May; 15(Suppl 1):i29-i32. PubMed ID: 35711295
[TBL] [Abstract][Full Text] [Related]
4. Long-term complications of systemic oxalosis in children-a retrospective single-center cohort study.
Ben-Shalom E; Cytter-Kuint R; Rinat C; Becker-Cohen R; Tzvi-Behr S; Goichberg J; Peles V; Frishberg Y
Pediatr Nephrol; 2021 Oct; 36(10):3123-3132. PubMed ID: 33651179
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperoxaluria: a rare but important cause of nephrolithiasis.
Wong PN; Tong GM; Lo KY; Mak SK; Law EL; Wong AK
Hong Kong Med J; 2002 Jun; 8(3):202-6. PubMed ID: 12055367
[TBL] [Abstract][Full Text] [Related]
6. Combined hepatic and renal transplantation in primary hyperoxaluria type I: clinical report of nine cases.
Watts RW; Morgan SH; Danpure CJ; Purkiss P; Calne RY; Rolles K; Baker LR; Mansell MA; Smith LH; Merion RM
Am J Med; 1991 Feb; 90(2):179-88. PubMed ID: 1996585
[TBL] [Abstract][Full Text] [Related]
7. Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis.
Pape L; Ahlenstiel-Grunow T; Birtel J; Krohne TU; Hoppe B
Pediatr Nephrol; 2020 Jun; 35(6):1121-1124. PubMed ID: 32107618
[TBL] [Abstract][Full Text] [Related]
8. Renal transplantation in primary hyperoxaluria.
Watts RW; Morgan SH; Mansell MA; Purkiss P
Ann Acad Med Singap; 1987 Apr; 16(2):337-9. PubMed ID: 3318661
[TBL] [Abstract][Full Text] [Related]
9. Type 1 primary hyperoxaluria: A case report and focus on bone impairment of systemic oxalosis.
Pijnenburg L; Caillard S; Boivin G; Rizzo S; Javier RM
Morphologie; 2018 Mar; 102(336):48-53. PubMed ID: 29102553
[TBL] [Abstract][Full Text] [Related]
10. An update on primary hyperoxaluria.
Hoppe B
Nat Rev Nephrol; 2012 Jun; 8(8):467-75. PubMed ID: 22688746
[TBL] [Abstract][Full Text] [Related]
11. [Interferent RNA treatment: Example of primary hyperoxaluria].
Cochat P; Sellier-Leclerc AL; Bertholet-Thomas A; Bacchetta J
Nephrol Ther; 2021 Apr; 17S():S23-S26. PubMed ID: 33910694
[TBL] [Abstract][Full Text] [Related]
12. Hyperoxaluria and systemic oxalosis: current therapy and future directions.
Bobrowski AE; Langman CB
Expert Opin Pharmacother; 2006 Oct; 7(14):1887-96. PubMed ID: 17020415
[TBL] [Abstract][Full Text] [Related]
13. Combined split liver and kidney transplantation in a three-year-old child with primary hyperoxaluria type 1 and complete thrombosis of the inferior vena cava.
Khan Z; Sciveres M; Salis P; Minervini M; Maggiore G; Cintorino D; Riva S; Gridelli B; Emma F; Spada M
Pediatr Transplant; 2011 Jun; 15(4):E64-70. PubMed ID: 19793227
[TBL] [Abstract][Full Text] [Related]
14. Liver and kidney transplant in primary hyperoxaluria: a single center experience.
Moray G; Tezcaner T; Özçay F; Baskın E; Akdur A; Kırnap M; Yıldırım S; Arslan G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():145-7. PubMed ID: 25894144
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria.
Bollée G; Cochat P; Daudon M
Can J Kidney Health Dis; 2015; 2():31. PubMed ID: 26380104
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary hyperoxaluria type 1.
Gupta A; Somers MJG; Baum MA
Clin Kidney J; 2022 May; 15(Suppl 1):i9-i13. PubMed ID: 35592620
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of primary hyperoxaluria after kidney transplantation.
Malakoutian T; Asgari M; Houshmand M; Mohammadi R; Aryani O; Mohammadi Pargoo E; Ghods AJ
Iran J Kidney Dis; 2011 Nov; 5(6):429-33. PubMed ID: 22057078
[TBL] [Abstract][Full Text] [Related]
18. Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions.
Beck BB; Hoyer-Kuhn H; Göbel H; Habbig S; Hoppe B
Expert Opin Investig Drugs; 2013 Jan; 22(1):117-29. PubMed ID: 23167815
[TBL] [Abstract][Full Text] [Related]
19. Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study.
Hoppe B; Pellikka PA; Dehmel B; Banos A; Lindner E; Herberg U
Nephrol Dial Transplant; 2021 Jul; 36(8):1464-1473. PubMed ID: 32810261
[TBL] [Abstract][Full Text] [Related]
20. The infant with primary hyperoxaluria and oxalosis: from diagnosis to multiorgan transplantation.
Bunchman TE; Majors H; Majors G; Gardner JJ; DeVee J; Dennerll EM; Hesford JL; Mitchell CL; Punch JD
Adv Ren Replace Ther; 1996 Oct; 3(4):315-25. PubMed ID: 8914696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
